201 related articles for article (PubMed ID: 15551046)
1. Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats.
Rotter Sopasakis V; Larsson BM; Johansson A; Holmäng A; Smith U
Diabetologia; 2004 Nov; 47(11):1879-87. PubMed ID: 15551046
[TBL] [Abstract][Full Text] [Related]
2. L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity.
Prada PO; Hirabara SM; Souza CT; Schenka AA; Zecchin HG; Vassallo J; Velloso LA; Carneiro E; Carvalheira JBC; Curi R; Saad MJ
Diabetologia; 2007 Sep; 50(9):1949-1959. PubMed ID: 17604977
[TBL] [Abstract][Full Text] [Related]
3. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway.
Ueno M; Carvalheira JB; Tambascia RC; Bezerra RM; Amaral ME; Carneiro EM; Folli F; Franchini KG; Saad MJ
Diabetologia; 2005 Mar; 48(3):506-18. PubMed ID: 15692808
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase.
Ogihara T; Asano T; Katagiri H; Sakoda H; Anai M; Shojima N; Ono H; Fujishiro M; Kushiyama A; Fukushima Y; Kikuchi M; Noguchi N; Aburatani H; Gotoh Y; Komuro I; Fujita T
Diabetologia; 2004 May; 47(5):794-805. PubMed ID: 15127200
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.
Kim HJ; Higashimori T; Park SY; Choi H; Dong J; Kim YJ; Noh HL; Cho YR; Cline G; Kim YB; Kim JK
Diabetes; 2004 Apr; 53(4):1060-7. PubMed ID: 15047622
[TBL] [Abstract][Full Text] [Related]
6. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.
Carey AL; Bruce CR; Sacchetti M; Anderson MJ; Olsen DB; Saltin B; Hawley JA; Febbraio MA
Diabetologia; 2004 Jun; 47(6):1029-37. PubMed ID: 15168015
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
9. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.
Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA
Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385
[TBL] [Abstract][Full Text] [Related]
11. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity.
Araújo EP; De Souza CT; Gasparetti AL; Ueno M; Boschero AC; Saad MJ; Velloso LA
Endocrinology; 2005 Mar; 146(3):1428-37. PubMed ID: 15550510
[TBL] [Abstract][Full Text] [Related]
12. A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.
Maegawa H; Obata T; Shibata T; Fujita T; Ugi S; Morino K; Nishio Y; Kojima H; Hidaka H; Haneda M; Yasuda H; Kikkawa R; Kashiwagi A
Diabetologia; 1999 Feb; 42(2):151-9. PubMed ID: 10064094
[TBL] [Abstract][Full Text] [Related]
13. Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.
Premilovac D; Attrill E; Rattigan S; Richards SM; Kim J; Keske MA
Cardiovasc Res; 2019 Mar; 115(3):590-601. PubMed ID: 30192915
[TBL] [Abstract][Full Text] [Related]
14. Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats.
Koopmans SJ; Leighton B; DeFronzo RA
Diabetologia; 1998 Jul; 41(7):813-20. PubMed ID: 9686923
[TBL] [Abstract][Full Text] [Related]
15. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.
Park S; Kim DS; Kwon DY; Yang HJ
J Neuroendocrinol; 2011 Aug; 23(8):687-98. PubMed ID: 21599766
[TBL] [Abstract][Full Text] [Related]
16. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
Li L; Yang G; Li Q; Tang Y; Li K
Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
[TBL] [Abstract][Full Text] [Related]
17. A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle.
Hussey SE; Lum H; Alvarez A; Cipriani Y; Garduño-Garcia J; Anaya L; Dube J; Musi N
Diabetologia; 2014 Mar; 57(3):582-91. PubMed ID: 24337154
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
Hoeks J; Hesselink MK; Russell AP; Mensink M; Saris WH; Mensink RP; Schrauwen P
Diabetologia; 2006 Oct; 49(10):2419-26. PubMed ID: 16896940
[TBL] [Abstract][Full Text] [Related]
20. Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats.
Holmes AG; Mesa JL; Neill BA; Chung J; Carey AL; Steinberg GR; Kemp BE; Southgate RJ; Lancaster GI; Bruce CR; Watt MJ; Febbraio MA
J Endocrinol; 2008 Aug; 198(2):367-74. PubMed ID: 18523033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
